It has the most potent weight-loss shot and a large experimental pipeline, including what is widely expected to be the first ...

GLP-1 drugs are being recommended on social media, raising questions about who can see the content and what the effects might ...

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...

As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

In phase 2, VK2735 reduced patients' weight by about 15% after 13 weeks of treatment and maintained a clean safety profile.

Mice given semaglutide, the key ingredient in drugs like Ozempic and Wegovy, lost weight, but they also voluntarily ran less on a wheel.

As you are likely aware, many people are using a class of drugs called GLP-1 receptor agonists for weight loss. One of the ...

Pfizer (NYSE: PFE) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...

Whilst it can work as an affective weight-loss drug for those who are obese, it should never be used for a short-term ...

The drug, initially intended for use by diabetics, has soared in popularity as a result of the weight-loss effects.

Scholar Rock is also working on a treatment that helps preserve lean muscle that is often lost during rapid weight loss by patients taking the new class of GLP-1 drugs. Scholar Rock's stock is down 45 ...